ÂÜÀòÂÒÂ×

Cheryl Demos Fludas is an accomplished professional in the field of clinical operations, currently serving as the Vice President of Clinical Operations at Taysha Gene Therapies. Previously, Cheryl held the position of Vice President and Head of Clinical Operations at Myrtelle Therapeutics and served as a Clinical Trial Leader at the Bill & Melinda Gates Medical Research Institute. Cheryl also worked as an Associate Director of Clinical Operations and Therapeutic Lead at Novartis Gene Therapies, as well as Director of Clinical Research at Clarus Therapeutics. Cheryl obtained an A.B. in Classics from Loyola University Chicago between 1985 and 1988 and has further educational credentials from the University of Illinois Chicago.